The study by Roger Stupp et al.1, published in NEJM in 2005, is considered the basis of current treatment for glioblastoma. It demonstrated for the first time that combined radiochemotherapy with Temozolomide provides a significant and clinically relevant survival benefit in the treatment of glioblastoma.
References